Core Viewpoint - The article emphasizes the importance of sustained outperformance by fund managers in the A-share market, highlighting the need for true alpha rather than high volatility smart beta. It identifies the "Guangfa Multi-Factor" fund as a standout performer, having outperformed major indices for seven consecutive years, a rarity in the market [1][6]. Fund Performance and Management - Guangfa Multi-Factor, managed by Yang Dong and Tang Xiaobin, has shown a diversified portfolio with a balanced style. Other funds managed by Yang Dong, such as Guangfa Value Navigator and Guangfa Balanced Growth, also reached new net value highs in July [2]. - As of June 30, 2025, Guangfa Multi-Factor achieved an absolute return of 11% in the first half of the year, with a cumulative return of 345.84% since inception and an annualized return of 19.21%. In comparison, the CSI 300 and CSI 800 indices rose by 19.36% and 11.76%, respectively [7]. Investment Strategy - Yang Dong employs a team-based, multi-strategy approach to achieve stable and sustainable excess returns, contrasting with single-manager fund management [3][4]. - The article discusses the significance of "continuity" in investment performance, noting that Guangfa Multi-Factor is one of only two active equity funds that have outperformed major indices consistently over the past seven years [6]. Fund Characteristics - The funds managed by Yang Dong are categorized into two types: core funds aimed at outperforming major indices and style-enhanced funds for more sophisticated investors [9]. - The article outlines the distinct characteristics of the funds, including their investment scope and holding patterns, with Guangfa Multi-Factor focusing on a broad market allocation while other funds target specific sectors [8][9]. Team and Strategy Integration - Yang Dong's team combines subjective and quantitative strategies to enhance investment performance, leveraging both macroeconomic insights and data-driven analysis [21][22]. - The article highlights the unique aspects of Yang Dong's team, including the management of diverse products, the collaborative effort in generating excess returns, and the specialized roles within the team [33]. Market Adaptation - The article notes that Yang Dong's team has demonstrated strong industry allocation capabilities, adjusting their strategies based on market conditions and sector performance [15]. - The funds have shown adaptability in their holdings, with significant changes in top positions reflecting market trends and opportunities [27][29].

Core Viewpoint - A significant number of active equity funds are experiencing a performance turnaround, with over 180 funds reaching new historical net asset value highs as of June 25, driven by market uptrends and favorable external factors [1][2]. Group 1: Performance of Active Equity Funds - Over 180 active equity funds have achieved historical net asset value highs, with more than half of these funds established for over a year, and some for nearly 14 years [1][2]. - The fund with the highest increase is Jin Yuan Shun An Yuan Qi, which has risen over 450% since its inception in November 2017, primarily investing in small-cap stocks [2][3]. - Other notable funds include Guangfa Multi-Factor and Dacheng Jingheng, with increases of over 340% and nearly 300% respectively, focusing on quantitative investment strategies [2][3]. Group 2: Market Trends and Investment Strategies - Approximately 80% of active equity funds have seen positive performance this year, with around 1,100 funds increasing by over 10%, particularly those focused on Hong Kong stocks, pharmaceuticals, and technology [3][4]. - The highest-performing fund this year is Huatai-PB Hong Kong Advantage Selection, which has increased by over 90%, primarily investing in the Hong Kong pharmaceutical sector [4]. - Three main investment directions have gained consensus among institutions: innovative pharmaceuticals, technology, and dividend stocks, with a preference for a "barbell" strategy that balances aggressive and defensive investments [4][5]. Group 3: Future Outlook and Recommendations - Fund managers suggest focusing on high-potential international pharmaceutical companies and stable dividend assets, especially in a declining interest rate environment [5][6]. - The AI sector is highlighted as a key area for investment, with significant growth in AI applications and user engagement noted [6][7]. - Overall, there is optimism for the A-share market, with recommendations to prioritize stable dividend returns and sectors with strong industrial and policy catalysts [7].